Back to search

Article

Beyond Exosomes: Ultrapurified Phospholipoproteic Complex (PLPC) as a Scalable Immunomodulatory Platform to Reprogram Immune Suppression in Metastatic Cancer

2025-04-07

Abstract excerpt

Dendritic exosomes (DEX) have demonstrated immunostimulatory potential in can-cer immunotherapy, but their clinical translation remains limited due to cryodepend-ence, heterogeneity, and poor scalability. To overcome these challenges, we developed a phospholipoprotein complex (PLPC), derived from dendritic cell secretomes and sta-bilized via ultracentrifugation and lyophilization. This study characterizes PLPC&rsq...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d4efcc04-f34d-5707-bc45-73469e803d16
DOI
10.20944/preprints202504.0471.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Beyond Exosomes: Ultrapurified Phospholipoproteic Complex (PLPC) as a Scalable Immunomodulatory Platform to Reprogram Immune Suppression in Metastatic CancerDOI 10.20944/preprints202504.0471.v1
Select a neighboring publication to make it the new centre.